Literature DB >> 19775910

Genetics and pathogenesis of multiple sclerosis.

R L Zuvich1, J L McCauley, M A Pericak-Vance, J L Haines.   

Abstract

Multiple sclerosis (MS) is an idiopathic autoimmune neurodegenerative disease. Like many common diseases, MS has a genetic component; however, as with most complex diseases, the genetic architecture may be influenced by heterogeneity, incomplete penetrance, polygenic inheritance, and environmental factors. This clinically complex disease has provided great challenges for geneticists over the years. Although the first consistent genetic association to MS (with HLA-DR*1501) was discovered more than 30 years ago, lack of consistently replicated genetic results has plagued the scientific community. New study design methods (particularly genome-wide associations studies [GWAS]) along with genome project data and larger datasets have allowed several additional MS genes to be identified and consistently replicated. Thus, after many years of frustration, the strong genetic component associated with MS is finally beginning to be characterized.

Entities:  

Mesh:

Year:  2009        PMID: 19775910      PMCID: PMC2789848          DOI: 10.1016/j.smim.2009.08.003

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  47 in total

Review 1.  Multiple sclerosis.

Authors:  J H Noseworthy; C Lucchinetti; M Rodriguez; B G Weinshenker
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

Review 2.  Genome-wide association studies: theoretical and practical concerns.

Authors:  William Y S Wang; Bryan J Barratt; David G Clayton; John A Todd
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

3.  A high-density screen for linkage in multiple sclerosis.

Authors:  Stephen Sawcer; Maria Ban; Mel Maranian; Tai Wai Yeo; Alastair Compston; Andrew Kirby; Mark J Daly; Philip L De Jager; Emily Walsh; Eric S Lander; John D Rioux; David A Hafler; Adrian Ivinson; Jacqueline Rimmler; Simon G Gregory; Silke Schmidt; Margaret A Pericak-Vance; Eva Akesson; Jan Hillert; Pameli Datta; Annette Oturai; Lars P Ryder; Hanne F Harbo; Anne Spurkland; Kjell-Morten Myhr; Mikko Laaksonen; David Booth; Robert Heard; Graeme Stewart; Robin Lincoln; Lisa F Barcellos; Stephen L Hauser; Jorge R Oksenberg; Shannon J Kenealy; Jonathan L Haines
Journal:  Am J Hum Genet       Date:  2005-07-29       Impact factor: 11.025

4.  A meta-analysis of genomic screens in multiple sclerosis. The Transatlantic Multiple Sclerosis Genetics Cooperative.

Authors: 
Journal:  Mult Scler       Date:  2001-02       Impact factor: 6.312

5.  Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Authors:  R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

Review 6.  Multiple sclerosis genetics: leaving no stone unturned.

Authors:  J R Oksenberg; L F Barcellos
Journal:  Genes Immun       Date:  2005-08       Impact factor: 2.676

7.  Genomewide scan of multiple sclerosis in Finnish multiplex families.

Authors:  S Kuokkanen; M Gschwend; J D Rioux; M J Daly; J D Terwilliger; P J Tienari; J Wikström; J Palo; L D Stein; T J Hudson; E S Lander; L Peltonen
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

8.  A second-generation genomic screen for multiple sclerosis.

Authors:  S J Kenealy; M-C Babron; Y Bradford; N Schnetz-Boutaud; J L Haines; J B Rimmler; S Schmidt; M A Pericak-Vance; L F Barcellos; R R Lincoln; J R Oksenberg; S L Hauser; M Clanet; D Brassat; G Edan; J Yaouanq; G Semana; I Cournu-Rebeix; O Lyon-Caen; B Fontaine
Journal:  Am J Hum Genet       Date:  2004-10-19       Impact factor: 11.025

Review 9.  Genetics of multiple sclerosis.

Authors:  David A Dyment; George C Ebers; A Dessa Sadovnick
Journal:  Lancet Neurol       Date:  2004-02       Impact factor: 44.182

10.  Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group.

Authors:  J L Haines; H A Terwedow; K Burgess; M A Pericak-Vance; J B Rimmler; E R Martin; J R Oksenberg; R Lincoln; D Y Zhang; D R Banatao; N Gatto; D E Goodkin; S L Hauser
Journal:  Hum Mol Genet       Date:  1998-08       Impact factor: 6.150

View more
  28 in total

Review 1.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Multiple sclerosis: autoimmune associations in multiple sclerosis.

Authors:  Cris S Constantinescu; Bruno Gran
Journal:  Nat Rev Neurol       Date:  2010-11       Impact factor: 42.937

3.  Genome-wide association study of severity in multiple sclerosis.

Authors: 
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

Review 4.  Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Christian M Hedrich; George C Tsokos
Journal:  Trends Mol Med       Date:  2011-08-30       Impact factor: 11.951

Review 5.  SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions.

Authors:  Cynthia Detre; Marton Keszei; Xavier Romero; George C Tsokos; Cox Terhorst
Journal:  Semin Immunopathol       Date:  2010-02-10       Impact factor: 9.623

6.  miRNAs in multiple sclerosis: regulating the regulators.

Authors:  Mireia Guerau-de-Arellano; Amy E Lovett-Racke; Michael K Racke
Journal:  J Neuroimmunol       Date:  2010-12-15       Impact factor: 3.478

7.  1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.

Authors:  Inna V Grishkan; Amanda N Fairchild; Peter A Calabresi; Anne R Gocke
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

8.  H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis.

Authors:  Naresha Saligrama; Rajkumar Noubade; Laure K Case; Matthew E Poynter; Cory Teuscher
Journal:  Cell Immunol       Date:  2012-07-14       Impact factor: 4.868

9.  CMV infection attenuates the disease course in a murine model of multiple sclerosis.

Authors:  Istvan Pirko; Rhonda Cardin; Yi Chen; Anne K Lohrey; Diana M Lindquist; R Scott Dunn; Robert Zivadinov; Aaron J Johnson
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

Review 10.  Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.

Authors:  Amedeo Amedei; Domenico Prisco; Mario Milco D'Elios
Journal:  Int J Mol Sci       Date:  2012-10-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.